SVR25
Showing 1 - 25 of 533
Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)
Recruiting
- Myelofibrosis
- Selinexor
- Physician's Choice Treatment
-
Los Angeles, California
- +41 more
Jan 30, 2023
Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)
Recruiting
- Myeloproliferative Neoplasms
-
Herston, Queensland, Australia
- +22 more
Jun 30, 2023
Atopic Dermatitis Trial (Cosmetic Product TOPIALYSE Baume Protect+)
Not yet recruiting
- Atopic Dermatitis
- Cosmetic Product TOPIALYSE Baume Protect+
- (no location specified)
Oct 25, 2023
Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)
Not yet recruiting
- Myelofibrosis
- TQ05105 Tablets
- TQB3617 Capsules
-
Guangzhou, Guangdong, China
- +19 more
Nov 7, 2023
Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)
Completed
- Chronic Hepatitis c Genotype 1
- Narlaprevir
- +2 more
-
Moscow, Russian Federation
- +4 more
Oct 27, 2022
HCV Infection Trial in Phnom Penh (Sofosbuvir/Daclatasvir)
Not yet recruiting
- HCV Infection
-
Phnom Penh, CambodiaClinical Trial Unit (Ctu)
Aug 7, 2023
Hemodynamic Instability, Epidural, Pregnancy Trial in Manresa (Levobupivacaine, Ropivacaine)
Not yet recruiting
- Hemodynamic Instability
- +3 more
-
Manresa, Barcelona, SpainAlthaia Xarxa Assitensial i Universitaria Manresa
May 17, 2023
Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))
Recruiting
- Hepatitis C
- Sofosbuvir 400mg [Sovaldi]
- Glecaprevir/pibrentasvir (300mg/120mg)
-
Darlinghurst, New South Wales, Australia
- +2 more
Mar 28, 2022
Hepatitis C Viral Trial in Dundee
Active, not recruiting
- Hepatitis C Viral
-
Dundee, United KingdomNHS Tayside
Nov 14, 2022
HCV Care and Treatment for HIV-HCV Co-infected Decentralised
Not yet recruiting
- HIV Infection
- Hepatitis C Infection
- Blood samples
-
Vinh, Nghe An, Vietnam
- +1 more
Aug 16, 2022
Chronic Hepatitis b Trial in Chisinau, Kyiv (ATI-2173 25mg, Vebicorvir 300mg, Viread 300Mg Tablet)
Terminated
- Chronic Hepatitis b
- ATI-2173 25mg
- +2 more
-
Chisinau, Republic Of Moldova, Moldova, Republic of
- +1 more
May 25, 2022
Living Donor Liver Transplantation Trial in Seoul (Clearsight (finger cuff))
Recruiting
- Living Donor Liver Transplantation
- Clearsight (finger cuff)
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 22, 2022
Against HCV Based on Direct-acting Antivirals in Real-life
Completed
- Chronic Hepatitis C Infection
- Telaprevir
- +10 more
-
Seville, Andalusia, SpainValme University Hospital
Jun 22, 2022
Point-of-Care Echocardiography to Assess Impact of Dynamic
Recruiting
- Cirrhosis, Liver
- +4 more
- Echocardiographic assessment
-
Chandigarh, Delhi, IndiaPGIMER
Jan 17, 2023
Coblopasvir Hydrochloride Capsules Combined With Sofosbuvir
Not yet recruiting
- Hepatitis C Infection
-
Beijing, Bejing, ChinaBejing Tsinghua Changgung Hospital
Oct 31, 2022
Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))
Completed
- Chronic Hepatitis C Virus (HCV) Infection Genotype 1
- ABT-450/r/ABT-267
- +2 more
-
Phoenix, Arizona
- +47 more
Jun 27, 2022
Hemodynamic Instability, Anesthesia, General, Anesthesia, Intravenous Trial in Haugesund (Ephedrine, Phenylephrine,
Recruiting
- Hemodynamic Instability
- +2 more
- Ephedrine
- +5 more
-
Haugesund, NorwayHelse Fonna, Haugesund Sykehus
Mar 18, 2022
Pulmonary Embolism, Pulmonary Embolus/Emboli, Pulmonary Disease Trial in Los Angeles (Non-invasive hemodynamic measurements)
Enrolling by invitation
- Pulmonary Embolism
- +5 more
- Non-invasive hemodynamic measurements
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Oct 31, 2022
Congenital Heart Disease in Children, Cardiopulmonary Bypass, Tetralogy of Fallot Trial in Jakarta (Dexmedetomidine Hcl 100
Recruiting
- Congenital Heart Disease in Children
- +2 more
- Dexmedetomidine Hcl 100 Mcg/mL Inj
- Placebo
-
Jakarta, IndonesiaNational Cardiovascular Center Harapan Kita Hospital Indonesia
Oct 11, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Hepatitis C Trial (Zinc Supplement)
Not yet recruiting
- Hepatitis C
- Zinc Supplement
- (no location specified)
Jul 16, 2022